Smoking and Diabetes Control in Adults With Type 1 and Type 2 Diabetes: A Nationwide Study From the 2018 National Program for Prevention and Control of Diabetes of Iran

被引:18
|
作者
Molla, Ghasem Janbabaei [1 ]
Ismail-Beigi, Faramarz [2 ]
Larijani, Bagher [3 ]
Khaloo, Pegah [4 ]
Moosaie, Fatemeh [4 ]
Alemi, Hamid [4 ]
Mansournia, Mohammad Ali [5 ]
Ghadimi, Tayyeb [6 ]
Ghaemi, Fatemeh [7 ]
Nakhjavani, Manouchehr [4 ]
Esteghamati, Alireza [4 ]
机构
[1] Minist Hlth & Med Educ, Curat Affairs, Tehran, Iran
[2] Case Western Reserve Univ, Dept Med Biochem Physiol & Biophys, Div Clin & Mol Endocrinol, Cleveland, OH 44106 USA
[3] Univ Tehran Med Sci, Diabet Researcher Ctr, Endocrinol & Metab Res Inst, Tehran, Iran
[4] Univ Tehran Med Sci, Vali Asr Hosp, Endocrinol & Metab Res Ctr, Sch Med, Tehran, Iran
[5] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran
[6] Iran Med Univ, Dept Surg, Tehran, Iran
[7] Minist Hlth & Med Educ, Dept Transplantat & Dis, Tehran, Iran
关键词
cardiovascular diseases (CVD); diabetes complications; diabetes nephropathies; diabetes retinopathy; glycemic/lipid control; smoking; CIGARETTE-SMOKING; RISK-FACTORS; PROGRESSION; NEUROPATHY; MORTALITY; MELLITUS; DISEASE;
D O I
10.1016/j.jcjd.2019.07.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Smoking is among the top leading causes of morbidity and mortality worldwide. To date, studies on the association between smoking and diabetes complications and metabolic control have shown conflicting results. In this study, we aimed to assess the association of smoking with micro- and macrovascular complications of diabetes and lipid and glycemic indices. Methods: We used the National Program for Prevention and Control of Diabetes of Iran database of 99,651 adult patients with diabetes across Iran. Multiple logistic regression models were used to examine the association between smoking and diabetes complications including cardiovascular disease, neuropathy, nephropathy and retinopathy. This association was adjusted for age, sex, duration of diabetes, glycated hemoglobin (A1C), hypertension, hyperlipidemia, medication, obesity and type of diabetes. Results: Smoking was associated with cardiovascular disease, nephropathy, retinopathy and neuropathy (odds ratios [ORs1 for patients with type 1 diabetes were 1.51, 2.29, 2.70 and 2.40, respectively; for patients with type 2 diabetes, ORs were 1.27, 1.21, 1.51 and 1.70, respectively; all with p values <0.001). Among patients with type 1 diabetes, smoking was significantly (p<0.05) associated with A1C (OR, 2.12), 2-h postglucose level (OR, 1.30), triglycerides (OR, 1.48) and high-density lipoprotein (HDL) control (OR, 1.34). Among patients with type 2 diabetes, smoking was significantly associated with A1C (OR, 1.09) and HDL control (OR, 1.21). Conclusions: Smoking was associated with multiple diabetes complications including cardiovascular disease, neuropathy, nephropathy and retinopathy and worse A1C and HDL control in both patients with type 1 and type 2 diabetes. It was also associated with worse 2-h postglucose level and triglyceride control among patients with type 1 diabetes. Our findings signify that national programs for smoking prevention and cessation may be beneficial to diabetes control in Iran. (C) 2019 Canadian Diabetes Association.
引用
收藏
页码:246 / 252
页数:7
相关论文
共 50 条
  • [21] Type 2 diabetes and frequency of prevention and control measures
    Jimenez-Corona, Aida
    Aguilar-Salinas, Carlos A.
    Rojas-Martinez, Rosalba
    Hernandez-Avila, Mauricio
    SALUD PUBLICA DE MEXICO, 2013, 55 : S137 - S143
  • [22] Periodontitis and Metabolic Control of Adults with Type 1 Diabetes
    Jeftha, A.
    Suliman, A.
    Conradie-Smit, M.
    Kimmie-Dhansay, F.
    JDR CLINICAL & TRANSLATIONAL RESEARCH, 2024, 9 (1_SUPPL) : 6S - 12S
  • [23] Metabolic Control in Emerging Adults with Type 1 Diabetes
    Monaghan, Maureen
    Alvarez, Vanessa
    Cogen, Fran R.
    Streisand, Randi
    DIABETES, 2011, 60 : A341 - A341
  • [24] Diabetes distress, illness perceptions and glycaemic control in adults with type 2 diabetes
    Martinez, Kelly
    Lockhart, Sam
    Davies, Mark
    Lindsay, John R.
    Dempster, Martin
    PSYCHOLOGY HEALTH & MEDICINE, 2018, 23 (02) : 171 - 177
  • [25] INSOMNIA AND GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES
    Chasens, E. R.
    Atwood, C. W.
    Baniak, L. M.
    Burke, L. E.
    Korytkowski, M.
    Morris, J. L.
    Sereika, S. M.
    Strollo, P. J.
    SLEEP, 2017, 40 : A377 - A378
  • [26] Comparison of cognitive function in older adults with type 1 diabetes, type 2 diabetes, and no diabetes: results from the Study of Longevity in Diabetes (SOLID)
    Lacy, Mary E.
    Moran, Chris
    Gilsanz, Paola
    Beeri, Michal S.
    Karter, Andrew J.
    Whitmer, Rachel A.
    BMJ OPEN DIABETES RESEARCH & CARE, 2022, 10 (02)
  • [27] BIDIRECTIONAL ASSOCIATIONS BETWEEN DEPRESSION AND TYPE 2 DIABETES IN ADULTS: RESULT FROM QINGDAO DIABETES PREVENTION PROGRAM
    Ning, F.
    Wang, Y. M.
    Wang, S. J.
    Nan, H. R.
    Sun, J. P.
    Zhang, D.
    Zhang, L.
    Gao, W. G.
    Pang, Z. C.
    Qiao, Q.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S2 - S2
  • [28] Effect of flash glucosemonitoring on glycaemic control in adults with type 1 diabetes: a nationwide, longitudinal observational study
    Nathanson, D.
    Svensson, A.
    Miftaraj, M.
    Franzen, S.
    Bolinder, J.
    Eeg-Olofsson, K.
    DIABETOLOGIA, 2019, 62 : S113 - S114
  • [29] Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes
    Kravarusic, Jelena
    Aleppo, Grazia
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2020, 49 (01) : 37 - +
  • [30] Moving diabetes care from science to practice: The evolution of the national diabetes prevention and control program
    Murphy, D
    Chapel, T
    Clark, C
    ANNALS OF INTERNAL MEDICINE, 2004, 140 (11) : 978 - 984